- United States
- /
- Healthcare Services
- /
- NasdaqGS:NRC
National Research (NASDAQ:NRC) Knows How To Allocate Capital Effectively
To find a multi-bagger stock, what are the underlying trends we should look for in a business? In a perfect world, we'd like to see a company investing more capital into its business and ideally the returns earned from that capital are also increasing. Basically this means that a company has profitable initiatives that it can continue to reinvest in, which is a trait of a compounding machine. Speaking of which, we noticed some great changes in National Research's (NASDAQ:NRC) returns on capital, so let's have a look.
What is Return On Capital Employed (ROCE)?
For those that aren't sure what ROCE is, it measures the amount of pre-tax profits a company can generate from the capital employed in its business. The formula for this calculation on National Research is:
Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)
0.45 = US$50m ÷ (US$153m - US$42m) (Based on the trailing twelve months to March 2022).
Therefore, National Research has an ROCE of 45%. That's a fantastic return and not only that, it outpaces the average of 10% earned by companies in a similar industry.
View our latest analysis for National Research
Historical performance is a great place to start when researching a stock so above you can see the gauge for National Research's ROCE against it's prior returns. If you want to delve into the historical earnings, revenue and cash flow of National Research, check out these free graphs here.
What The Trend Of ROCE Can Tell Us
The trends we've noticed at National Research are quite reassuring. The data shows that returns on capital have increased substantially over the last five years to 45%. The amount of capital employed has increased too, by 22%. So we're very much inspired by what we're seeing at National Research thanks to its ability to profitably reinvest capital.
The Key Takeaway
In summary, it's great to see that National Research can compound returns by consistently reinvesting capital at increasing rates of return, because these are some of the key ingredients of those highly sought after multi-baggers. Investors may not be impressed by the favorable underlying trends yet because over the last five years the stock has only returned 38% to shareholders. So exploring more about this stock could uncover a good opportunity, if the valuation and other metrics stack up.
On a final note, we've found 2 warning signs for National Research that we think you should be aware of.
High returns are a key ingredient to strong performance, so check out our free list ofstocks earning high returns on equity with solid balance sheets.
Valuation is complex, but we're here to simplify it.
Discover if National Research might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NasdaqGS:NRC
National Research
Provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience.
Good value second-rate dividend payer.